The immunohistochemical prognostic factors that are assessed in order to plan a surgical and medical treatment for breast cancer are estrogen receptors (ER), progesterone receptors (PR), and epidermal growth factor (HER-2) (4). This evidence concerns the gene PGR and breast carcinoma.